Tamper-resistant oxycodone tablets have no impact on overall opioid use or harm

Led by the National Drug and Alcohol Research Centre (NDARC) at University of New South Wales Sydney, the National Opioid Medications Abuse Deterrence (Nomad) study is the most comprehensive analysis of the impact of tamper-resistant opioid formulations to date.